Generative AI may help people breathe better

Nvidia GPUs prove to be good medicine in biotech company’s work in drug discovery.

Robert Dow

When Insilico Medicine was founded nearly 10 years ago, AI technology was in its very early stages. But, Insilico’s founder saw AI as a revolutionary method to advance drug discovery—and do so without having to resort to animal testing. Today, that gamble on AI is saving the company substantial time and money throughout the entire process. Using Nvidia’s GPUs, Insilico is now entering Phase II clinical trials with a drug candidate for a relatively rare respiratory disease that was discovered using generative AI. I want a new drug One that won’t make me sick… So go the lyrics of the

Enjoy full access with a TechWatch subscription!

TechWatch is the front line of JPR information gathering service, comprising current stories of interest to the graphics industry spanning the core areas of graphics hardware and software, workstations, gaming, and design.

A subscription to TechWatch includes 4 hours of consulting time to be used over the course of the subscription.

Already a subscriber? Login below

This content is restricted

Subscribe to TechWatch